Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KC’s first Hispanic beer company craft-brews conversations beyond stereotypes
Defining his own cultural identity has been a lifelong struggle for Damon Arredondo, the longtime brewer said. Coming from a mixed-cultural background, Arredondo often felt as if there was “a checklist” that decided whether or not he was able to identify with his heritage, he shared. “Only recently in the last five year have I…
Veteran entrepreneur finds security in pizza, opening new Rosati’s in south Overland Park
Bob Ring sold his homegrown company of 25 years — then got a job delivering pizzas. All part of the recipe for the longtime Kansas City businessman who — despite his decades of experience — initially found banks hesitant to lend to him during the pandemic as he worked to open his own pizzeria in…
Camel Culture tastes like home: How a Missouri dairy’s milk fills a void when everything else seems foreign
Startland News’ Startup Road Trip series explores innovative and uncommon ideas finding success in rural America and Midwestern startup hubs outside the Kansas City metro. This series is possible thanks to the Ewing Marion Kauffman Foundation, which leads a collaborative, nationwide effort to identify and remove large and small barriers to new business creation. MILLER,…
Fund Me, KC: Her startup has outgrown its puppy phase; now’s your chance to feed its potential
Startland News is continuing its “Fund Me, KC” series to highlight area entrepreneurs’ efforts to accelerate their businesses or lend a helping hand to others. This is an opportunity for business owners and innovators — like Jonaie Johnson’s effort to publicly launch the highly-anticipated PlayTach smart dog crate attachment by Interplay — to share their…